These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 11603000

  • 1. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
    Najjar F, Hustinx R, Jerusalem G, Fillet G, Rigo P.
    Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY, Kao A, Yen RF.
    Oncol Rep; 2002 Aug; 9(2):321-5. PubMed ID: 11836600
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
    Thill R, Neuerburg J, Fabry U, Cremerius U, Wagenknecht G, Hellwig D, Osieka R, Günther R, Büll U.
    Nuklearmedizin; 1997 Oct; 36(7):234-9. PubMed ID: 9441282
    [Abstract] [Full Text] [Related]

  • 5. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G.
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
    [Abstract] [Full Text] [Related]

  • 6. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma.
    Tatsumi M, Kitayama H, Sugahara H, Tokita N, Nakamura H, Kanakura Y, Nishimura T.
    J Nucl Med; 2001 Apr; 42(4):601-8. PubMed ID: 11337549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN.
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [Abstract] [Full Text] [Related]

  • 10. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Jerusalem G, Warland V, Najjar F, Paulus P, Fassotte MF, Fillet G, Rigo P.
    Nucl Med Commun; 1999 Jan; 20(1):13-20. PubMed ID: 9949408
    [Abstract] [Full Text] [Related]

  • 11. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
    Blum RH, Seymour JF, Wirth A, MacManus M, Hicks RJ.
    Clin Lymphoma; 2003 Jun; 4(1):43-9. PubMed ID: 12837154
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.
    Cancer; 2002 Feb 15; 94(4):879-88. PubMed ID: 11920454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
    Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME.
    J Nucl Med; 1997 Mar 15; 38(3):343-8. PubMed ID: 9074514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 18F-fluorodeoxyglucose-positron emission tomography in the staging of malignant lymphoma compared with CT and 67Ga scan.
    Hong SP, Hahn JS, Lee JD, Bae SW, Youn MJ.
    Yonsei Med J; 2003 Oct 30; 44(5):779-86. PubMed ID: 14584092
    [Abstract] [Full Text] [Related]

  • 19. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
    Mittal BR, Manohar K, Malhotra P, Das R, Kashyap R, Bhattacharya A, Varma N, Varma S.
    Leuk Lymphoma; 2011 Nov 30; 52(11):2111-6. PubMed ID: 21745169
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.